Physician profile
Omar Hernandez
NPI 1912169210
$2,178.78
in general payments reported to CMS, 2019-2025
8 companies · $621 in 2025
The $621 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.35 · 2022: $35.99 · 2023: $1,308 · 2024: $195 · 2025: $621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,359 · Food and Beverage: $766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,358.82 |
| Food and Beverage | $765.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,071.52 | 2023 | Mc3 Nautilus(Tm) Ecmo Oxygenator |
| Stryker Corporation | $459.97 | 2025 | Clottriever Bold Catheter |
| Abiomed | $340.98 | 2024-2025 | Impella |
| Abbott Laboratories | $108.53 | 2023 | 2nd Gen Centrimag Primary Console |
| Dexcom, INC. | $106.76 | 2023 | Dexcom G7 Gss (161) |
| Glaxosmithkline, LLC. | $48.34 | 2022-2025 | Bexsero, Shingrix, Arexvy |
| Pfizer INC. | $30.39 | 2021-2022 | |
| Dynavax Technologies Corporation | $12.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.